OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Table. 1.

Table. 1.

Antimicrobial resistance patterns of CA-MRSA clinical isolates in Korea

Reference Total (N) Antimicrobial resistance (N)

ERY CLI CIP GEN Fusidic acid TET RIF TMP_SMX
Joo, et al. 2012 [9] 84 36 21 2
Shin, et al. 2016 [10] 36 16 0 1 11 5
Lee, et al. 2011 [11] 29 18 18 0
Ko, et al. 2008 [12] 18 12 7 3 9 3 0
Sung, et al. 2012 [13] 40 24 8 7 14 7 1 1
Kim, et al. 2008 [14] 25 14 14 0 2 1 0 0
Peck, et al. 2009 [15] 36 32 30 30 30 26 2 3
Bae, et al. 2010 [16] 42 25 2 3 6 3 0 1
Moon, et al. 2010 [17] 2 1 1 0 0 0 0 0
Kwon, et al. 2011 [18] 58 44 39
Park, et al. 2015 [19] 79 28 18 5 12 0 0 0
Bae, et al. 2019 [20] 16 4 4 4 4 2 1
Choi, et al. [22] (Unpublished data) 299 83 61 34 47 8 9 6 2
Overall resistance, N (%) 764 293/706 (41.50) 229/764 (29.97) 131/651 (20.12) 135/593 (22.77) 12/478 (2.51) 94/601 (15.64) 9/597 (1.51) 7/579 (1.21)

Abbreviations: CA-MRSA, community-associated methicillin-resistant Staphylococcus aureus; CLI, clindamycin; ERY, erythromycin; CIP, ciprofloxacin; GEN, Gentamycin; TET, Tetracycine; RIF, Rifampicin; TMP_SMX, trimethoprim/sulfamethoxazole.

Ann Lab Med 2021;41:386~393

© Ann Lab Med